Lista de obras -

A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review

artículo científico publicado en 2020

A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy

article

Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta.

artículo científico publicado en 2003

Age-related changes of serum N-acetyl-aspartate in healthy controls

artículo científico publicado en 2011

Age-related disability in multiple sclerosis

artículo científico publicado en 2002

Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.

artículo científico publicado en 2005

Atypical forms of multiple sclerosis or different phases of a same disease?

artículo científico publicado en 2004

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.

artículo científico publicado en 2013

Defining the course of tumefactive multiple sclerosis: a large retrospective multicentre study

scientific article published on 10 December 2020

Durvalumab and multiple sclerosis: a causal link or simple unmasking?

artículo científico publicado en 2020

Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score.

artículo científico publicado en 2007

Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy

artículo científico publicado en 2020

Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis

scientific article published on 01 January 2020

Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender

scientific article published on 16 March 2012

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.

artículo científico publicado en 2012

Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

article

Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study

artículo científico publicado en 2016

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

artículo científico publicado en 2015

Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort.

artículo científico publicado en 2017

Geographical variations in sex ratio trends over time in multiple sclerosis.

artículo científico publicado en 2012

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

artículo científico

Immunomodulatory therapies delay disease progression in multiple sclerosis

artículo científico publicado en 2012

Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study

artículo científico publicado en 2012

Italian Multiple Sclerosis Database Network

article

Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study.

artículo científico publicado en 2015

Low serum urate levels are associated to female gender in multiple sclerosis patients.

artículo científico publicado en 2012

Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients.

artículo científico publicado en 2016

Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics

artículo científico publicado en 2020

New natural history of interferon-β-treated relapsing multiple sclerosis

artículo científico publicado en 2007

PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels

scientific article published on 11 April 2020

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study

artículo científico publicado en 2014

Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment.

artículo científico publicado en 2009

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs

artículo científico publicado en 2014

Predictors of disability worsening in clinically isolated syndrome.

artículo científico publicado en 2015

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

artículo científico publicado en 2012

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks

artículo científico publicado en 2018

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks

artículo científico publicado en 2018

Prognostic indicators in pediatric clinically isolated syndrome

artículo científico publicado en 2017

Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.

artículo científico publicado en 2009

Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register

artículo científico publicado en 2019

The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy

artículo científico publicado en 2016

The IFNβ treatment of multiple sclerosis (MS) in clinical practice: the experience at the MS Center of Bari, Italy

article

The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNβ exposure in multiple sclerosis

article

The MoSt Project––More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy

article

The impact of neutralizing antibodies on the risk of disease worsening in interferon β–treated relapsing multiple sclerosis: a 5 year post-marketing study ⬇️

artículo científico publicado el 17 de febrero de 2013

Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study

scientific article published on 10 February 2014

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors

artículo científico publicado en 2020

Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study).

artículo científico publicado en 2014

Variations of the perforin gene in patients with multiple sclerosis

article

Lista de obras de

A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review

A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy

Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta.

Age-related changes of serum N-acetyl-aspartate in healthy controls

Age-related disability in multiple sclerosis

Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.

Atypical forms of multiple sclerosis or different phases of a same disease?

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.

Defining the course of tumefactive multiple sclerosis: a large retrospective multicentre study

Durvalumab and multiple sclerosis: a causal link or simple unmasking?

Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score.

Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy

Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis

Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.

Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort.

Geographical variations in sex ratio trends over time in multiple sclerosis.

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

Immunomodulatory therapies delay disease progression in multiple sclerosis

Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study

Italian Multiple Sclerosis Database Network

Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study.

Low serum urate levels are associated to female gender in multiple sclerosis patients.

Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients.

Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics

New natural history of interferon-β-treated relapsing multiple sclerosis

PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study

Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment.

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs

Predictors of disability worsening in clinically isolated syndrome.

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks

Prognostic indicators in pediatric clinically isolated syndrome

Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.

Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register

The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy

The IFNβ treatment of multiple sclerosis (MS) in clinical practice: the experience at the MS Center of Bari, Italy

The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNβ exposure in multiple sclerosis

The MoSt Project––More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy

The impact of neutralizing antibodies on the risk of disease worsening in interferon β–treated relapsing multiple sclerosis: a 5 year post-marketing study ⬇️

Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors

Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study).

Variations of the perforin gene in patients with multiple sclerosis